Abstract

BackgroundThe problem of drug resistance and toxicity in trypanosomiasis is ever-increasing, thereby creating a need to search for efficacious and safer alternatives that are of plant origin. We designed the present study to assess the oral acute toxicity, and anti-trypanosomal activity of Brillantaisia owariensis in mice.MethodsFifty-eight BALB/c mice were used for this study. For toxicity assessment, eighteen mice were divided into two groups of nine mice each, and acute single oral administration of the aqueous and methanol whole plant extracts of B. owariensis was assessed for each group as per Lorke’s method. Mice were observed for signs of toxicity of liver and kidney organs after two weeks of oral administration. For the anti-trypanosomal activity, forty mice were divided into eight groups of five mice. Mouse in each group was inoculated with 0.1 mL containing106T. brucei /mL. Following patency of 3 days, mice were treated at different dosages of methanol and aqueous extracts. Pre-infection, post-infection, and post-treatment data for rectal temperature, body weight, parasiteamia level, packed cell volume, and daily survival were monitored.ResultsThe acute oral toxicity studies (LD50) for methanol and aqueous plant extracts in this study were calculated as 3535 mg/kg/body weight, and are non-toxic. No obvious histopathologic observation in the liver and kidney tissues. The mean daily rectal temperature and mean weights of all the treated mice were restored to normal values and significant (P, 0.05) in comparison to the positive control.Parasitaemia clearance by both extracts was suppressive. The mean PCV values were significantly increased following treatment, and there was prolonged survival especially in mice treated with methanol extracts.ConclusionThe study concludes that the extracts of B. owariensis are relatively non-toxic with a good safety margin when administered to mice orally. Crude methanol extract exhibited better suppressive and haematinic antitrypanosomal activities than the aqueous extract, and it has a promising effect by its ability to reduce anaemia in mice challenged with T. brucei brucei, and prolonged survival.

Highlights

  • IntroductionControl of trypanosomiasis is principally achieved by chemoprophylactic or chemotherapeutic agents [4]

  • Trypanosomiasis is a neglected tropical infectious disease of medical and veterinary importance in sub-Sahara Africa caused by a protozoan parasite of the genus Trypanosoma

  • The study concludes that the extracts of B. owariensis are relatively non-toxic with a good safety margin when administered to mice orally

Read more

Summary

Introduction

Control of trypanosomiasis is principally achieved by chemoprophylactic or chemotherapeutic agents [4]. Most of these drugs for the control of both animals and humans are chemically related [5]. It has been estimated that as many as 35 million doses of trypanocides are used annually in sub-Saharan Africa alone [6]. This represents a figure suitable to treat only around one-third of the cattle at risk [7]. The chemotherapy of African trypanosomiasis is limited by problems of scarcity of drugs, drug resistance, high price, adverse reaction and toxicity [8, 9]. We designed the present study to assess the oral acute toxicity, and anti-trypanosomal activity of Brillantaisia owariensis in mice

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call